Per Winkel

Medicine & Life Sciences

1. Randomized Controlled Trials 100%
2. Placebos 35%
3. Coronary Disease 33%
4. Coronary Artery Disease 31%
5. Citalopram 26%
6. Cardiac Rehabilitation 26%
7. Mortality 26%
8. Clarithromycin 25%
9. Implantable Defibrillators 23%
10. Confidence Intervals 21%
11. Rehabilitation 20%
12. Induced Hypothermia 17%
13. Depression 16%
14. Eczema 16%
15. Coronary Artery Bypass 15%
16. Exercise 15%
17. Therapeutics 15%
18. Septic Shock 14%
19. Prenatal Education 14%
20. Near-Infrared Spectroscopy 14%
21. Control Groups 13%
22. Biomarkers 13%
23. Hand 13%
24. Education 13%
25. Myocardial Ischemia 12%
26. Ringer's acetate 12%
27. Extremely Premature Infants 12%
28. Multicenter Studies 12%
29. Social Skills 12%
30. Cognitive Behavioral Therapy 12%
31. Starch 12%
32. Pregnancy-Associated Plasma Protein-A 11%
33. Serum 11%
34. Major Depressive Disorder 11%
35. Out-of-Hospital Cardiac Arrest 11%
36. Myocardial Infarction 10%
37. Osteoprotegerin 10%
38. Resuscitation 10%
39. Mentalization 10%
40. Quality of Life 10%
41. Brain Natriuretic Peptide 9%
42. Health Care Outcome Assessment 9%
43. Brain Hypoxia 9%
44. Random Allocation 9%
45. Quality Control 8%
46. Hydroxymethylglutaryl-CoA Reductase Inhibitors 8%
47. Phase II Clinical Trials 8%
48. Sepsis 8%
49. Hemoglobins 8%
50. Phase III Clinical Trials 8%